Literature DB >> 20421003

Open versus endovascular intervention for critical limb ischemia: a population-based study.

David L Cull1, Eugene M Langan, Bruce H Gray, Brent Johnson, Spence M Taylor.   

Abstract

BACKGROUND: Endovascular techniques are considered by many as the first-line treatment for critical limb ischemia (CLI). The purpose of this study is to assess the impact of endovascular therapy on CLI and amputation in South Carolina during the past decade. STUDY
DESIGN: This is a retrospective, comparative analysis of treatment outcomes for CLI in the pre-endovascular era and the endovascular era. The South Carolina Office of Research and Statistics database was reviewed using ICD-9 diagnosis and procedure codes to identify patients who underwent limb revascularization in 1996 (pre-endovascular era) and 2005 (endovascular era) for CLI and to determine those who required subsequent limb amputation and additional revascularization.
RESULTS: The index limb revascularization procedures increased 33% from 571 in 1996 (420 [74%] open; 151 [26%] endovascular) to 758 in 2005 (373 [49%] open; 385 [51%] endovascular). The demographics and comorbidities for patients who underwent revascularization in 1996 were similar to those in 2005. The amputation rate for patients who underwent a revascularization procedure was 34% at 1 year and 43% at 3 years in 1996, compared with 34% at 1 year and 40% at 3 years in 2005 (p = NS). The percentage of patients who required an additional revascularization in the same calendar year increased from 8% in 1996 to 19% in 2005 (p < 0.001).
CONCLUSIONS: Although there has been an absolute increase in the number of revascularization procedures for CLI, with a clear shift toward endovascular therapy, the amputation rates for these patients have not changed. However, the shift to endovascular interventions has increased the number of secondary procedures required to maintain limb-salvage rates equivalent to those of the pre-endovascular era. Copyright 2010 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20421003     DOI: 10.1016/j.jamcollsurg.2009.12.019

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  7 in total

1.  Management of critical lower limb ischemia in endovascular era: experience from 511 patients.

Authors:  Baker Ghoneim; Hussein Elwan; Waleed Eldaly; Hussein Khairy; Ahmad Taha; Amr Gad
Journal:  Int J Angiol       Date:  2014-09

2.  Comparison of the Incidence of Complications and Secondary Surgical Interventions Necessary in Patients with Chronic Lower Limb Ischemia Treated by Both Open and Endovascular Surgeries.

Authors:  Dariusz Janczak; Maciej Malinowski; Wojciech Bąkowski; Katarzyna Krakowska; Karol Marschollek; Paweł Marschollek; Mariusz Chabowski
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-05-11       Impact factor: 1.520

3.  Association of Human Immunodeficiency Virus Infection and Risk of Peripheral Artery Disease.

Authors:  Joshua A Beckman; Meredith S Duncan; Charles W Alcorn; Kaku So-Armah; Adeel A Butt; Matthew Bidwell Goetz; Hilary A Tindle; Jason J Sico; Russel P Tracy; Amy C Justice; Matthew S Freiberg
Journal:  Circulation       Date:  2018-03-13       Impact factor: 29.690

4.  Population-Based Trends in Amputations and Revascularizations for Peripheral Artery Disease From 1990 to 2009.

Authors:  Jeffrey J Nienaber; Carin Y Smith; Stephen Cha; Mateus Correa; Phillip G Rowse; Kent R Bailey; Manju Kalra
Journal:  Mayo Clin Proc       Date:  2022-02-15       Impact factor: 11.104

5.  Population-Based Study of Incidence, Risk Factors, Outcome, and Prognosis of Ischemic Peripheral Arterial Events: Implications for Prevention.

Authors:  Dominic P J Howard; Amitava Banerjee; Jack F Fairhead; Linda Hands; Louise E Silver; Peter M Rothwell
Journal:  Circulation       Date:  2015-09-08       Impact factor: 29.690

6.  Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs.

Authors:  Kimberly M Brayton; Alan T Hirsch; Patricia J O Brien; Andrea Cheville; Pinar Karaca-Mandic; Stanley G Rockson
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

7.  The CLEAR (Considering Leading Experts' Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention.

Authors:  Kitty H F Wong; Dave C Bosanquet; Graeme K Ambler; Mahim I Qureshi; Robert J Hinchliffe; Christopher P Twine
Journal:  CVIR Endovasc       Date:  2019-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.